TRENDS AND KEY DECISION DRIVERS FOR REJECTING AN ORPHAN DRUG SUBMISSION ACROSS FIVE DIFFERENT HTA AGENCIES

被引：5

|

作者：

Mardiguian, S. ^{[1
]}

Stefanidou, M. ^{[1
]}

Sheppard, F. ^{[1
]}

机构：

[1] PAREXEL, London, England

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.1140

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PHP204

引用

收藏

页码：A438 / A438

页数：1

相关论文

共 3 条

[1] EXPLORING THE KEY DECISION DRIVERS PROVIDED BY HTA AGENCIES REJECTING SUBMISSIONS WITH ICERS LOWER THAN THE THRESHOLD
Walsh, S. C. M.
Goodrich, K.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A482 - A482
[2] REIMBURSEMENT DECISION LANDSCAPE FOR ORPHAN DRUGS ACROSS SIX HTA AGENCIES
Mittal, L. K.
Banerjee, P.
Kapoor, A.
Ligade, V. S.
[J]. VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
[3] EXPLORING THE KEY DECISION DRIVERS PROVIDED BY HTA AGENCIES ACCEPTING SUBMISSIONS WITH ICERS HIGHER THAN THE THRESHOLD
Goodrich, K.
Walsh, S. C. M.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A480 - A480